Bolt Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
CEOWilliam P. Quinn
CEOWilliam P. Quinn
Employees52
Employees52
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2015
Founded2015
Employees52
Employees52
BOLT Key Statistics
Market cap12.31M
Market cap12.31M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume1.34M
Average volume1.34M
High today$0.32
High today$0.32
Low today$0.2998
Low today$0.2998
Open price$0.31
Open price$0.31
Volume175.55K
Volume175.55K
52 Week high$0.795
52 Week high$0.795
52 Week low$0.281
52 Week low$0.281
People also own
Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.